Novartis has a much-anticipated approval for its spinal muscular atrophy (SMA) treatment onasemnogene abeparvovec in the US, getting a green light for a new version that can make more patients ...
Roche and PTC Therapeutics' Evrysdi for spinal muscular atrophy (SMA) has been approved by the FDA for younger children with the rare disease, extending its use to include infants less than two months ...
POINCIANA, Fla. — The Central Florida Expressway Authority is moving forward with a project that was once dubbed the Great Wall of Poinciana. After facing backlash from the community, and even a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results